BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26438828)

  • 1. SAM68 is a physiological regulator of SMN2 splicing in spinal muscular atrophy.
    Pagliarini V; Pelosi L; Bustamante MB; Nobili A; Berardinelli MG; D'Amelio M; Musarò A; Sette C
    J Cell Biol; 2015 Oct; 211(1):77-90. PubMed ID: 26438828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The splicing regulator Sam68 binds to a novel exonic splicing silencer and functions in SMN2 alternative splicing in spinal muscular atrophy.
    Pedrotti S; Bielli P; Paronetto MP; Ciccosanti F; Fimia GM; Stamm S; Manley JL; Sette C
    EMBO J; 2010 Apr; 29(7):1235-47. PubMed ID: 20186123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function analysis of Sam68 and hnRNP A1 synergy in the exclusion of exon 7 from SMN2 transcripts.
    Nadal M; Anton R; Dorca-Arévalo J; Estébanez-Perpiñá E; Tizzano EF; Fuentes-Prior P
    Protein Sci; 2023 Apr; 32(4):e4553. PubMed ID: 36560896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hnRNP M facilitates exon 7 inclusion of SMN2 pre-mRNA in spinal muscular atrophy by targeting an enhancer on exon 7.
    Cho S; Moon H; Loh TJ; Oh HK; Cho S; Choy HE; Song WK; Chun JS; Zheng X; Shen H
    Biochim Biophys Acta; 2014; 1839(4):306-15. PubMed ID: 24533984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia is a modifier of SMN2 splicing and disease severity in a severe SMA mouse model.
    Bebee TW; Dominguez CE; Samadzadeh-Tarighat S; Akehurst KL; Chandler DS
    Hum Mol Genet; 2012 Oct; 21(19):4301-13. PubMed ID: 22763238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy.
    Kashima T; Manley JL
    Nat Genet; 2003 Aug; 34(4):460-3. PubMed ID: 12833158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy: a new player joins the battle for SMN2 exon 7 splicing.
    Pedrotti S; Sette C
    Cell Cycle; 2010 Oct; 9(19):3874-9. PubMed ID: 20890126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2.
    Cartegni L; Hastings ML; Calarco JA; de Stanchina E; Krainer AR
    Am J Hum Genet; 2006 Jan; 78(1):63-77. PubMed ID: 16385450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Securinine enhances SMN2 exon 7 inclusion in spinal muscular atrophy cells.
    Chen YC; Chang JG; Liu TY; Jong YJ; Cheng WL; Yuo CY
    Biomed Pharmacother; 2017 Apr; 88():708-714. PubMed ID: 28152480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
    Kashima T; Rao N; David CJ; Manley JL
    Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A negatively acting bifunctional RNA increases survival motor neuron both in vitro and in vivo.
    Dickson A; Osman E; Lorson CL
    Hum Gene Ther; 2008 Nov; 19(11):1307-15. PubMed ID: 19848583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene.
    Seo J; Singh NN; Ottesen EW; Sivanesan S; Shishimorova M; Singh RN
    PLoS One; 2016; 11(4):e0154390. PubMed ID: 27111068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy.
    Singh NN; Androphy EJ; Singh RN
    Biochem Biophys Res Commun; 2004 Mar; 315(2):381-8. PubMed ID: 14766219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.
    Hofmann Y; Wirth B
    Hum Mol Genet; 2002 Aug; 11(17):2037-49. PubMed ID: 12165565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells.
    Yuo CY; Lin HH; Chang YS; Yang WK; Chang JG
    Ann Neurol; 2008 Jan; 63(1):26-34. PubMed ID: 17924536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
    Wee CD; Havens MA; Jodelka FM; Hastings ML
    PLoS One; 2014; 9(12):e115205. PubMed ID: 25506695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3' splice site.
    Doktor TK; Schroeder LD; Vested A; Palmfeldt J; Andersen HS; Gregersen N; Andresen BS
    Hum Mutat; 2011 Feb; 32(2):220-30. PubMed ID: 21120954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare SMN2 variant in a previously unrecognized composite splicing regulatory element induces exon 7 inclusion and reduces the clinical severity of spinal muscular atrophy.
    Vezain M; Saugier-Veber P; Goina E; Touraine R; Manel V; Toutain A; Fehrenbach S; Frébourg T; Pagani F; Tosi M; Martins A
    Hum Mutat; 2010 Jan; 31(1):E1110-25. PubMed ID: 19953646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular pH change modulates the exon 7 splicing in SMN2 mRNA.
    Chen YC; Yuo CY; Yang WK; Jong YJ; Lin HH; Chang YS; Chang JG
    Mol Cell Neurosci; 2008 Oct; 39(2):268-72. PubMed ID: 18672065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of SMN trans-splicing and a neurotrophic factor increases the life span and body mass in a severe model of spinal muscular atrophy.
    Shababi M; Glascock J; Lorson CL
    Hum Gene Ther; 2011 Feb; 22(2):135-44. PubMed ID: 20804424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.